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Abstract
Background: An important question in dengue pathogenesis is the identity of immune cells involved in the control of
dengue virus infection at the site of the mosquito bite. There is evidence that infection of immature myeloid dendritic cells
plays a crucial role in dengue pathogenesis and that the interaction of the viral envelope E glycoprotein with CD209/DC-
SIGN is a key element for their productive infection. Dermal macrophages express CD209, yet little is known about their role
in dengue virus infection.
Methods and Findings: Here, we showed that dermal macrophages bound recombinant envelope E glycoprotein fused to
green fluorescent protein. Because dermal macrophages stain for IL-10 in situ, we generated dermal-type macrophages
from monocytes in the presence of IL-10 to study their infection by dengue virus. The macrophages were able to internalize
the virus, but progeny virus production was undetectable in the infected cells. In addition, no IFN-a was produced in
response to the virus. The inability of dengue virus to grow in the macrophages was attributable to accumulation of
internalized virus particles into poorly-acidified phagosomes.
Conclusions: Aborting infection by viral sequestration in early phagosomes would present a novel means to curb infection
of enveloped virus and may constitute a prime defense system to prevent dengue virus spread shortly after the bite of the
infected mosquito.
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Introduction
Dengue is probably the most important mosquito-transmitted
viral disease of humans worldwide. It is caused by dengue virus
(DV), which exists as four serotypes (DV1-4) and circulates in an
endemic-epidemic mode in most tropical and sub-tropical
territories. Transmission of DV to humans occurs when an
infected mosquito probes for blood vessels and during a blood
meal, through injection of infectious saliva into the human dermis.
As a member of the Flaviviridae family, DV infection involves virus
uptake into endosomal vesicles that undergo acidification. The low
pH induces structural alterations in the envelope (E) protein that
lead to membrane fusion and the release of the nucleocapsid into
the cytoplasm [1]. After uncoating, the RNA genome is translated
to initiate virus replication. It has been proposed that non-
neutralizing antibodies raised against one DV serotype may
enhance infection by a heterotypic serotype [2]. This may explain
why secondary infections are often associated with the more severe
forms of dengue fever (hemorrhagic fever with or without shock).
Much research on DV relies on relevant human cell culture
models due to the difficulty of establishing appropriate animal
models. Progress has been made by showing that DV E protein
recognizes the C-type lectin CD209 and its homologue L-SIGN
and that expression of either of these lectins is sufficient to render
cells permissive to DV grown in mosquito cells [3,4]. Recently, the
mannose receptor (MR) has also been shown to mediate DV
binding and infection [5]. Dendritic cells (DC), generated from
monocytes in the presence of GM-CSF and IL-4, express CD209,
L-SIGN and the MR and are highly susceptible to DV infection
[3,4,6]. These monocyte-derived DC are thought to be represen-
tative of dermal DC (dDC), yet there is increasing evidence that
CD209 is not expressed by dDC but primarily by dermal
macrophages (dMQ) [7–9]. This underscores the importance of
dMQ in early infection events and raises the question of whether
www.plosntds.org 1 October 2008 | Volume 2 | Issue 10 | e311dMQ are permissive for productive DV infection. Studies of these
cells have been hampered by the lack of suitable isolation
techniques from human skin and culture methods to generate
the cells from monocytic precursors.
Here, we confirmed that human dMQ express CD209 and
showed that they bind DV E protein. Based on the finding that
dMQ stained for intracellular IL-10, we developed a method to
generate the cells from monocytes in the presence of IL-10. The
monocyte-derived dMQ bound E protein and acquired DV in
intracellular vesicles, but were resistant to viral replication. The
inability of DV to grow in these dermal-type MQ was attributable
to accumulation of internalized virus particles into poorly-acidified
phagosomes. These findings advance our understanding of the
host innate resistance to DV at the early stages of infection and
have implications for other pathogens recognizing CD209.
Materials and Methods
Dermal cell suspensions
Before blood and tissue samples were collected for the study, all
healthy donors and patients gave written informed consent in
agreement with the Helsinki Declaration and French legislation. A
prospective IRB approval was not obtained since there was no
need as specified by French law of the health protection act when
employing healthy material destined for disposal or one-time
biomedical research. A retrospective IRB approval was given.
Fresh skin (about 50 cm
2) was obtained from patients undergoing
breast reduction surgery or abdominoplasty. The skin was
trypsinized to peel off the epidermis and the remaining dermis
was processed as described elsewhere [10] with the modification
that only collagenase type I (1 mg/ml, Invitrogen) was used for
18 h at 37uC. The resulting cell suspension was pipetted and
serially filtered through 100 mm and 70 mm cell strainers (BD
Biosciences) to remove undigested tissue fragments and to obtain a
homogeneous cell suspension.
Protein sE-eGFP production
A DNA fragment containing the DV3 genomic region (Swiss-Prot
accession number P27915) coding for the prM-E protein (1674 nt in
total, including all of prM and the E ectodomain, ending at codon
392 of E, at the end of domain III) was amplified by PCR with
forward primer 59TTATGCATATTACTGGCCGTCGTGGCC
and reverse primer 59CTCGCCCGCAGACATGGCCTTATCG-
TCATCGTCGGGCCCCTTCCTGTACCA-GTTGATTTT and
inserted into the plasmid pT352. This is a shuttle vector containing
selection markers for yeast and E. coli, as well as a metallotheionein-
inducible expression cassette for Drosophila cells. In the construct,
called pT352/DV3 sE-GFP, the DV prM-E sequence is in-frame
with the Drosophila BiP signal peptide, which directs the
recombinant protein to the secretory pathway. Drosophila S2 cells
(Invitrogen) were co-transfected with pT352/DV3 sE-GFP and a
vector conferring resistance to blasticidine, using the effectene
transfection reagent (Qiagen). The selected cells were adapted to
serum-free growth medium and grown to high density before
induction with CuSO4 at 500 mM. The supernatant was collected
10 days later and concentrated using a flow concentration system
with a 10 KDa-cutoff membrane (Vivascience), and DV3 sE-GFP
was purified by affinity chromatography using a Steptactin column.
The eluate was concentrated and further purified by size-exclusion
chromatography, using a Superdex 200 10/300 column (GE
Healthcare) with 0.5 M NaCl and 50 mM Tris (pH 8.0). Purified
DV3sEwasconcentratedto10 g/literinVivaspinultrafiltrationspin
columns (Sartorius).
DV3 sE protein binding and CD209 expression of dermal
cells
Dermal cells were collected 48 h after culturing in complete
medium, RPMI medium supplemented 10% fetal calf serum
(FCS) and antibiotics (Invitrogen), and 3610
5 cells were incubated
with 1, 2, 4 or 8 mg recombinant DV3 sE-eGFP fusion protein in
0.1 ml complete medium at 37uC for 30 min. The cells were then
washed twice with complete medium and incubated with anti-
CD14-APC, anti-CD1a-PE and anti-HLA-DR-PerCP mAb (BD
Biosciences) in PBS/2% FCS for 15 min. Following 3 washes, the
cells were fixed in 0.4% formaldehyde and analyzed by flow
cytometry (FACS Calibur, BD Biosciences). The relative MFI for
3 donors was determined in triplicate after gating for CD1a
+HLA-
DR
+ or CD14
+HLA-DR
+ cells using the following formula: (MFI
(FL1) protein sE-eGFP – MFI (FL1) no protein sE-eGFP)/MFI
(FL1) no protein sE-eGFP. To determine CD209 expression,
3610
5 cells were incubated with anti-CD209-PerCPCy5.5 (clone
DCN46, BD Biosciences), anti-CD14-APC, anti-CD1a-PE and
anti-HLA-DR-PerCP mAb in PBS/2% FCS for 15 min and, after
washing, fixed and analyzed by flow cytometry.
Immunofluorescence of skin sections
Formaldehyde-fixed, paraffin sections were rehydrated and
antigen was retrieved in citrate buffer pH 6 at 97uC for 45 min.
Biotin was blocked using the avidin-biotin blocking kit (Vector
Inc.), and sections were saturated in 5% human serum at room
temperature for 40 min. The following primary Abs were used:
goat-anti IL-10 (1:75 dilution, R&D Systems), mouse anti-CD209
(2 mg/ml, R&D Systems), mouse anti-CD1a (Immunotech) and
mouse anti-CD14 (1:40 dilution, Novocastra). The secondary Ab
(Jackson) were: biotin-conjugated donkey anti-goat followed by
streptavidin-Alexa 488 (Molecular Probes-Invitrogen) and F(ab)’2
rabbit anti-mouse followed by Cy3-conjugated donkey anti-rabbit.
Sections were observed by confocal microscopy (LSM510 Zeiss).
Cell culture and phenotypic analysis
Monocytes were isolated from 200 ml of adult human peripheral
blood using negative-depletion beads (Dynal-Invitrogen) or by
counterflow centrifugal elutriation. To obtain MDdMQ,3 610
6
monocytes were cultured for 5 days in 5 ml of complete medium
containing 10 ng/ml M-CSF (R&D Systems), 20 ng/ml IL-10
Author Summary
Mosquito-transmitted pathogens are a major challenge to
humans due to ever-increasing distribution of the vector
worldwide. Dengue virus causes morbidity and mortality,
and no anti-viral treatment or vaccine are currently
available. The virus is injected into the skin when an
infected mosquito probes for blood. Among the skin
immunocytes, dendritic cells and macrophages are
equipped with pathogen-sensing receptors. Our work
has shown that dermal macrophages bind the dengue
virus envelope protein. We demonstrate that monocyte-
derived dermal macrophages are resistant to infection and
present evidence that this is due to sequestration of the
virus into fusion-incompetent intracellular vesicles. This
identifies skin macrophages as the first innate immune cell
potentially capable of protecting the human host from
infection by dengue virus shortly after a mosquito bite.
These findings have important implications for better
understanding the early infection events of dengue virus
and of other skin-penetrating pathogens.
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refreshment of GM-CSF (10 ng/ml) and IL-10 (10 ng/ml) at day 3.
For MDDC, 3610
6 monocytes were cultured for 5 days in 5 ml of
complete medium containing 50 ng/ml GM-CSF and 10 ng/ml
IL-4 (Schering-Plough) with readdition of cytokines at day 3. Non-
adherent cells were harvested. Expression of markers was measured
by FACS using specific antibodies and their corresponding isotype
controls. To assay for DV3 sE protein binding, cells were pre-
incubated for 10 min in complete medium in the absence or
presence of 5 mM EDTA before adding 3 mg DV3 sE-eGFP
protein. After 30 min at 37uC, the cells were washed three times in
complete medium and analyzed by flow cytometry.
Viral infections
5610
5 MDdMQ and MDDC were exposed to DV serotype 1
(strain FGA/NA d1d) [11], serotype 2 (strain 16681), or serotype 3
(strain PaH 881, isolated in 1988 in Thailand) in RPMI medium
supplemented with 0.2% bovine serum albumin for 2 h. Viral
growth was determined at 40 h post-infection. Virus titration was
performed as previously described [3]. Infectivity titers were
expressed as focus forming unit (FFU) on mosquito AP61 cell line
(DV1 and DV3) or plaque forming unit (PFU) on mammalian
BHK cell line (DV2). Different titering assays were performed to
independently confirm our findings, despite the fact both methods
may not be equivalent. The limit of titer determination was fixed
at 10
3, below which viral production was considered non-
significant. For FACS analysis, infected cells were fixed and
labeled for intracellular viral antigens with antiserum raised in
mice that had received intracerebral DV injection [3]. IFN-a
released from DV1-infected MDdMQ and MDDC was measured
by ELISA (R&D Systems).
Microscopy on cultured cells
To observe live DV internalization by MDDC and MDdMQ,
the cells were exposed to DV1 at an MOI of 100 at 4uC for
30 min or at 37uC for 1 h and fixed in 2.5% glutaraldehyde. Cells
were postfixed in osmium tetroxide, dehydrated in ethanol
containing 1% uranyl acetate, treated with propylene oxide and
embedded in resin (Durcupan ACM, Fluka). Ultrathin sections
were stained with lead citrate and examined by transmission
electron microscopy (TEM) (Hitachi H600). Images were acquired
using a CCD camera (Hamamatsu). To visualize DV3 sE-eGFP
internalization and endosomal acidification, cells were incubated
with 10 mM LysoSensor Blue DND-167 (Molecular Probes-
Invitrogen) for 30 min at 37uC. Protein sE-eGFP was added at a
concentration of 3 mg/ml, and cells were viewed after different
incubation times using a confocal microscope (LSM510, Zeiss).
The blue color emitted by the LysoSensor dye was digitally
converted into red. For TEM, cells were fixed in 2% paraformal-
dehyde and 0.2% glutaraldehyde. Cells were embedded in 1%
agarose, permeabilized with 0.2% saponin and saturated with 2%
BSA before incubation with 5 mg/ml polyclonal rabbit anti-GFP
antibody (Rockland). The antibody was visualized by pre-
embedding labeling using a goat anti-rabbit IgG conjugated to
0.8 nm gold particles, according to manufacturer’s instructions
(Aurion). Cells were fixed in 1% glutaraldehyde, and gold particles
were enhanced using a silver kit (HQ silver, Nanoprobes). Cells
were then treated and observed as above.
Results
We wished to determine whether human dMQ are targets of DV
infection. To this end, healthy human skin from patients undergoing
plastic surgery was processed to obtain a dermal cell suspension. The
cells were then cultured without additional cytokines for 48 h to allow
re-expression of cell surface markers, such as CD1a and CD209, lost
during the collagenasetreatment (data not shown).Binding of DV3 E
protein to dermal cells was assessed by flow cytometry after staining
with CD14 and CD1a-specific antibodies. CD14 is expressed by
dMQ and CD1a by dDC [7–9]. To detect E protein binding, the
soluble form of DV3 E protein (sE) was fused to the reporter protein
eGFP and purified from a Drosophila expression system. As shown in
Figure 1A,C D 1 a
+ dDC showed only a limited capacity to interact
with DV3 sE protein, whereas CD14
+ dMQ readily bound the
protein. This is corroborated by the distinct expression of CD209 by
dMQ (Fig. 1A), whereas dDC expressed little, if any, CD209 (data
not shown). Increasing amounts of DV3 sE protein were added to the
dermal cell suspension to test if dDC bound the protein at higher
concentrations. Figure 1B s h o w st h a te v e na th i g hc o n c e n t r a t i o n s ,
there was little binding of DV3 sE protein to dDC, whereas it bound
to dMQ in a dose-dependent fashion. These findings identify dMQ as
potential key cellular targets of DV.
To address the question of whether dMQ are infected by DV
and whether they are permissive for viral production, we
established cell culture conditions to generate dermal-type MQ
from monocytes. We observed on human skin tissue sections that
dMQ expressing CD14 or CD209, but not the CD1a
+ dDC,
stained for IL-10 (Fig. 2A). When purified human monocytes
were cultured in M-CSF and increasing concentrations of IL-10,
the cells expressed CD14 and CD209 in an IL-10 dose-dependent
manner (Fig. 2B). Similar to DC [12], the addition of GM-CSF
increased CD209 levels (Fig. 2B), so that a homogeneous
CD14
+CD209
+ cell population could be obtained with CD209
expression nearly identical to that of DC derived from monocytes
in the presence of GM-CSF and IL-4 (Figure S1A). Western
blotting of cell lysates confirmed the presence of CD209 as a major
band of 49 kDa in both cell-types [13] (Figure S1B). The MQ
expressed coagulation factor XIIIa and CD163, two other cell
surface markers of dMQ [14] (Fig. 2C). The MQ and the DC were
both able to bind eGFP-tagged DV3 sE protein, which was
inhibited by EDTA (Fig. 2C). This distinguishes the monocyte-
derived DC from dDC. Upon activation by lipopolysaccharide
(LPS), the MQ rapidly released IL-10, whereas DC or monocytes
produced little of this cytokine (Figure S1C).
Monocyte-derived dMQ (MDdMQ) and monocyte-derived DC
(MDDC)wereanalyzedforDVinfectionusinglow-passageDV1and
DV3 strains grown inmosquito cells [3] as wellas the prototype DV2
strain 16681 [15]. The cells were exposed to DV1 at a multiplicity of
infection (MOI) of 1 for 2 h, washed, and then cultured for 40 h. As
shown in Figure 3A, intracellular viral antigen was clearly detected
in MDDC by flow cytometry, whereas no specific immuno-labeling
was observed in MDdMQ. An analysis of DV replication in these cells
infected at an MOI of 1 (DV1 and DV3) or 2 (DV2) showed that
MDDC were highly permissive to productive infection (,10
5 FFU/
ml or PFU/ml) (Fig. 3B); in contrast, progeny virus production was
undetectable in DV-infected MDdMQ (,10
3 FFU/ml or PFU/ml).
Consistent with this finding, no IFN-a was produced by DV-infected
MDdMQ, even at an MOI of 10, whereas MDDC readily released
IFN-a when infected with DV at an MOI of 1 or 10 [16] (Fig. 3C).
To verify that MDdMQ acquired the virus, both myeloid cell-types
were exposed to high DV input (MOI of 100) and electron
microscopy analysis was performed after 30 min at 4uC and after
1ha t3 7 uC( Fig. 3D). Cell surface-bound (at 4uC) and endosomal
vesicle-associated virus particles (at 37uC) were clearly detected in
both cell-types. Thus, internalization of DV can occur in MDdMQ
but does not result in productive infection.
In an effort to define the molecular basis of the inability of DV to
grow in MDdMQ. we asked whether internalized DV was
CD209+ Macrophages Resist Dengue Virus
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DV3 sE-eGFP fusion protein. To monitor DV3 sE protein
internalization in MDdMQ and MDDC, the cells were incubated
with pH-sensitive LysoSensor dye and analyzed by confocal
microscopy (Fig. 4). This dye accumulates in acidic organelles,
where its fluorescence emission is highest. After 5 min at 37uC, DV3
sEprotein was observed in vesicle-like structures in both cell-types. By
30 min and 60 min, DV3 sE protein dispersed to acidified
perinuclear lysosomes in MDDC. In marked contrast, when
MDdMQ were examined at these time-points, a large fraction of
internalized DV3 sE protein was excluded from the acidic
compartmentandremained innon-acidic,largeendosomes.Electron
microscopy analysis using a colloidal gold-conjugated antibody to
GFP demonstrated that DV3 sE protein accumulated in large
phagosomes in MDdMQ, located close to the plasma membrane
(Fig. 5) .O nt h eo t h e rh a n d ,a t3 0m i n ,i nM D D C ,D V 3s Ep r o t e i n
was mostly found in small perinuclear vesicles in the environment of
the endoplasmic reticulum. Taken together, these data suggest that
the inability of DV to productively infect MDdMQ is due to
accumulationofvirusparticlesinimmatureendosomalvesicleswhose
pH does not allow efficient viral-cell membrane fusion and
subsequent virus uncoating.
Discussion
In the present study, we demonstrated for the first time the
interaction of dMQ with DV3 sE glycoprotein, which correlates
with the expression of the DV attachment receptor CD209.
Dermal DC displayed only a limited capacity to interact with DV3
sE protein and expressed little CD209. In accordance with these
findings, in situ immuno-labeling of human skin section revealed
CD209 expression by dMQ but little on DC [7–9]. Both cell types
carry the MR [7], which also recognizes DV E protein [5]. Due to
the nature of our binding assay, the dermal cells with the highest
affinity for DV3 sE protein would acquire the most DV3 sE
protein, suggesting that dDC may capture the recombinant
envelope protein when physically isolated from dMQ. In the skin,
the abundance, the location and the co-expression of CD209, L-
SIGN and MR are likely to determine the nature of the DV-
capturing immune cell.
Based on the observations that dMQ stained for intracellular IL-
10 in situ and that IL-10 is produced by dMQ ex vivo [17,18], we
tested the effect of IL-10 on the formation of dMQ from
monocytes. By combining IL-10, M-CSF and GM-CSF, a
homogenous cell population was obtained which carried CD209
and other markers characteristic of dMQ, rapidly produced IL-10
in response to LPS or other toll-like receptor ligands (data not
shown), and bound DV3 sE protein. Like MDDC, the MDdMQ
were capable of internalizing live DV but, distinct from MDDC,
they displayed an inherent resistance to viral growth. In contrast to
DV3 sE protein found in acidified compartments in MDDC, we
observed that DV3 sE protein accumulated in non-acidified
phagosomes in MDdMQ ˜. The DC vesicles containing DV3 sE
protein or live virus were bell-shaped or tubular, whereas they
Figure 1. Dermal MQ bind DV3 sE protein. A. The single-cell dermal suspension was incubated without (None) or with 2 mg of DV3 sE-eGFP
fusion protein for 30 min at 37uC, washed, labeled for CD1a and CD14, and analyzed by flow cytometry. Live and large cells were pre-gated using the
FSC/SSC channels. To test for CD209 expression, the cell suspension was incubated with anti-CD209 mAb or its isotype control together with anti-
CD14 mAb and analyzed by flow cytometry. Arrows point to DV3 sE protein
+ cells. The data is representative of 4 donors. B. The cell suspension was
incubated with increasing amounts of DV3 sE-eGFP protein before labeling for CD1a, CD14 and HLA-DR. The relative mean fluorescence intensity
(MFI) of DV3 sE protein was determined for CD14
+HLA-DR
+ (dMQ) and CD1a
+HLA-DR
+ (dDC) cells and shown as a function of DV3 sE-eGFP protein
concentration. The analysis was performed in triplicate (mean6SD) for 3 donors.
doi:10.1371/journal.pntd.0000311.g001
CD209+ Macrophages Resist Dengue Virus
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To our knowledge, this identifies MDdMQ as the first innate
immune cell capable of protecting the human host from DV
infection and virus propagation. From this data, we propose that
dMQ can act to trap infecting virions in a fusion-incompetent
endosomal environment and thus to prevent DV spread to dDC at
the anatomical site of the mosquito bite. We cannot formally
exclude the possibility that downstream delays in the viral life cycle
Figure 2. Generation of dermal-type MQ with IL-10. A. Human CD14
+ and CD209
+ dMQ stained for IL-10. Formaldehyde-fixed sections of
human skin were incubated with anti-IL-10 goat Ab and anti-CD14, anti-CD209 or anti-CD1a mAb. The goat Ab was detected using a biotin-labeled
donkey anti-goat Ab, followed by streptavidin-Alexa 488, and the mAbs were revealed by rabbit anti-mouse Ab followed by Cy3-donkey anti-rabbit
Ab. The data is representative of 3 donors. The dotted line delimits the dermo-epidermal junction. B. Adult blood monocytes were cultured for
5 days in medium containing fetal calf serum and 10 ng/ml M-CSF without or with a low (10 ng/ml) or a high (30 ng/ml, bold type) concentration of
IL-10 in the absence or presence of 30 ng/ml GM-CSF. Non-adherent cells were collected and, after gating for viable cells, were analyzed for
expression of CD14 and CD209. Dot plot quadrants were placed according to isotype controls. C. Dermal-type MQ were generated in M-CSF/IL-10/
GM-CSF as in panel B and compared to DC obtained from monocytes in GM-CSF and IL-4. Expression of cell surface markers was measured by FACS.
Specific staining is in black and isotype controls are in grey. DV3 sE-eGFP protein binding was measured by FACS after incubating the cells with DV3
sE protein in the absence or presence of EDTA. Shown in black is the fluorescence of cells incubated with DV3 sE-eGFP protein and in grey is
fluorescence of cells without the fusion protein.
doi:10.1371/journal.pntd.0000311.g002
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finding that West Nile virus productively infects these cells (data
not shown) indicates that they are not generally refractory to
flavivirus growth.
IL-10, required for CD209 expression and blockage of
endosome acidification, is likely to be produced by the dMQ
themselves, constitutively, or in response to stimuli such as UV-
light [17]. In this context, a key question is whether mosquito
salivary proteins, co-injected with the infectious virus, would also
trigger IL-10 production by dMQ or, on the contrary, provoke an
inflammatory response. Inflammatory cytokines of the Th2 T-
helper cell type, IL-4 and IL-13, may be responsible for the
formation of CD209
+MR
+ DC, which are permissive for DV
infection and viral progeny production [3–6]. Alternatively, the
presence of anti-DV non-neutralizing antibodies raised against a
heterotypic DV serotype may render dDC susceptible to DV
infection at the site of the mosquito bite.
The abundance and strategic position of the MQ in the dermis is
consistent with their function as first defense barrier against
pathogens by isolating and eliminating them and thus avoiding
unnecessary immune activation. However, other pathogens that
recognize C-type lectins, such as mycobacteria, may exploit these
cells to escape immune attack. Accumulating CD209
+ MQ in
leprosy skin lesions have been associated with mycobacterial
persistence [19]. Important questions to address in future are
whether DV is eliminated in MDdMQ, whether infected MDdMQ
gradually release DV, as shown for the foot-and-mouth disease
virus and pulmonary MQ [20], and whether rapid DV growth can
occur when the Ma convert to DC. Improved knowledge of the
molecular mechanisms for suppressing pathogen growth in
MDdMQ will provide new insight into the crucial role of dMQ
in protective immunity to infectious agents at the skin level.
Supporting Information
Figure S1 Comparison of monocyte-derived DC and dermal-
type macrophages
Found at: doi:10.1371/journal.pntd.0000311.s001 (0.95 MB TIF)
Alternative Language Abstract S1 Translation of the abstract
into French by M. Decossas
Figure 3. MDdMQ are resistant to permissive DV infection. A. 5610
5 MDDC and MDdMQ were exposed to DV1 at an MOI of 1 for 2 h, washed,
and after 40 h processed for intracellular DV antigen detection by FACS. Graph shows the mean %6SD of intracellular DV antigens from 4 donors. * is
significant (p,0.05) by the two-tailed student’s t-test. B. Focus/plaque-forming assays (FFU/PFU) showing the mean titers6SD of DV1, 2 and 3 from
supernatants of MDDC and MDdMQ (3 donors each). 5610
5 cells were exposed to DV1 and DV3 at an MOI of 1 and to DV2 at an MOI of 2 for 2 h,
washed, and after 40 h, the supernatant was collected. The infectious titer was determined on AP61 cells (DV1 and DV3) and on BHK cells (DV2). C.
IFN-a secretion of non-infected (Mock) or infected MDDC and MDdMQ was determined with increasing MOI of DV1. The data is expressed as the
mean6SD of triplicate values and is representative of 3 donors. D. Both cell-types were exposed to DV1 at an MOI of 100. Transmission electron
micrograph showing virions bound to plasma membranes at 4uC, and internalization into vesicles 1 h after exposure to virus at 37uC.
doi:10.1371/journal.pntd.0000311.g003
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www.plosntds.org 6 October 2008 | Volume 2 | Issue 10 | e311Figure 4. DV3 sE-eGFP protein is excluded from acidic compartments in MDdMQ. Confocal microscopic analysis of the localization of DV3
sE-eGFP protein at different time-points in cells loaded with the fluorescent LysoSensor dye (optimal fluorescence at pH 5.1). For the overlay images,
blue color was converted to red to allow better co-visualization with eGFP. After 5 min incubation, sE-eGFP was endocytosed into vesicles close to
the plasma membrane in both cells types. After 30 min and 60 min, sE-eGFP-containing vesicles acidified in the perinuclear area in MDDC, whereas in
MDdMQ, sE-eGFP remained in non-acidified, large vesicles. The data is representative of 3 experiments.
doi:10.1371/journal.pntd.0000311.g004
Figure 5. DV3 sE-eGFP protein-containing vesicles are distinct in MDDC and MDdMQ. Cells were processed for electron-microscopic
localization of sE-eGFP using gold-conjugated anti-GFP Ab followed by silver enhancement. Five min after incubation with sE-eGFP, the protein was
bound to the plasma membrane (arrow heads) and entered both cell-types in small endosomes, invaginated from the plasma membrane (arrows). At
30 min, in MDDC, sE-eGFP was localized to small, peri-nuclear endosomes, often associated with the ER, whereas in MDdMQ, the sE-eGFP was
concentrated in large phagosomes. The inset shows a high-magnification view of sE-eGFP inside a tubular-shaped vesicle.
doi:10.1371/journal.pntd.0000311.g005
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